JQH(002885)
Search documents
京泉华(002885) - 第二期员工持股计划第一次持有人会议决议公告
2025-09-09 10:46
证券代码:002885 证券简称:京泉华 公告编号:2025-053 深圳市京泉华科技股份有限公司 第二期员工持股计划第一次持有人会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、持有人会议召开情况 深圳市京泉华科技股份有限公司(以下简称"公司")第二期员工持股计划 (以下简称"本次员工持股计划")第一次持有人会议通知已于 2025 年 9 月 4 日 以书面结合通讯方式送达全体持有人。本次会议于 2025 年 9 月 8 日在公司会议 室以现场结合通讯的表决方式召开。本次会议由董事会秘书曹文智先生召集和主 持。本次会议出席的持有人共 50 名,代表本次员工持股计划份额为 16,025,940 份,占公司本次员工持股计划份额总数的 100%。 参与本次员工持股计划的公司监事(第四届监事会)、高级管理人员合计 6 人自愿放弃其在持有人会议的提案权、表决权,且承诺不担任管理委员会任何职 务。上述监事、高级管理人员合计持有本次员工持股计划份额 3,213,000 份,未 参与本次会议所有议案的提案及表决,因此出席本次会议的有效表决份额总数为 12,8 ...
京泉华(002885) - 关于持股5%以上股东减持股份触及1%整数倍的公告
2025-09-09 09:48
深圳市京泉华科技股份有限公司(以下称"公司"或"京泉华")于 2025 年 7 月 29 日披露了《关于持股 5%以上股东减持股份预披露公告》(公告编号: 2025-044),持有公司股份 36,709,072 股的股东深圳远致富海高新投资企业(有 限合伙)(以下简称"远致高新")计划自公告披露之日起 15 个交易日后的三 个月内(2025 年 8 月 19 日至 2025 年 11 月 18 日,根据法律法规禁止减持的期 间除外)以集中竞价方式减持其所持有的部分公司股份,拟减持的股份合计为 2,693,600 股。 公司于近日收到持股 5%以上股东远致高新《关于减持公司股份比例触及 1% 整数倍的告知函》,截至 2025 年 9 月 8 日,远致高新通过集中竞价方式减持公 司股份共计 1,480,000 股,占公司总股本的 0.55%。现将具体情况公告如下: | 信息披露义务人 | 深圳远致富海高新投资企业(有限合伙) | | --- | --- | | 住所 | 深圳市福田区福田街道福安社区福华一路6号免税商务大厦 2601楼 | | 权益变动时间 | 2025年8月19日至2025年9月8日 | | 权 ...
京泉华(002885) - 关于持股5%以上股东及董事减持计划期限届满暨实施情况的公告
2025-09-08 12:33
证券代码:002885 证券简称:京泉华 公告编号:2025-051 深圳市京泉华科技股份有限公司 关于持股 5%以上股东及董事减持计划期限届满 暨实施情况的公告 公司持股 5%以上股东窦晓月女士以及公司董事鞠万金先生保证向公司提供的信 息内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 截至本公告披露日,公司持股 5%以上股东窦晓月女士以及公司董事鞠万金先生减持计划期 限已届满,窦晓月女士仍持有公司股份 28,192,985 股,占公司总股份的 10.41%;鞠万金先生仍 持有公司股份 6,220,312 股,占公司总股份的 2.30%。本次权益变动不会导致公司控制权发生变 化,不会导致公司基本面发生重大变化,亦不会影响公司的治理结构和持续经营。 深圳市京泉华科技股份有限公司(以下简称"公司")于 2025 年 5 月 15 日披露了《关于持股 5%以上股东及董事减持股份预披露的公告》(公告编号: 2025-026)。公司持股 5%以上股东窦晓月女士计划在减持预披露公告披露之日 起 15 个交易日之后的 3 个月内以集中 ...
京泉华:新能源领域一直是公司聚焦的核心业务领域
Zheng Quan Ri Bao Wang· 2025-09-04 11:13
Group 1 - The core focus of the company is in the new energy sector, which is also a key driver of business growth [1] - By the first half of 2025, the revenue from the new energy sector is expected to account for a significant proportion of the company's total operating income [1]
京泉华2025年中报简析:营收净利润同比双双增长,应收账款上升
Zheng Quan Zhi Xing· 2025-08-28 22:59
Financial Performance - The company reported a total revenue of 1.724 billion yuan for the first half of 2025, representing a year-on-year increase of 29.84% [1] - The net profit attributable to shareholders was 41.296 million yuan, up 11.45% year-on-year [1] - In Q2 2025, the total revenue was 931 million yuan, showing a year-on-year growth of 24.9%, while the net profit for the same quarter was 23.1073 million yuan, down 18.0% year-on-year [1] Key Financial Metrics - Gross margin increased to 12.7%, up 5.32% year-on-year, while net margin decreased to 2.43%, down 12.57% year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 74.2296 million yuan, accounting for 4.31% of revenue, a decrease of 10.08% year-on-year [1] - Earnings per share rose to 0.15 yuan, reflecting a 12.1% increase year-on-year, while operating cash flow per share decreased to 0.09 yuan, down 44.29% year-on-year [1] Accounts Receivable and Cash Flow - Accounts receivable increased significantly, with a year-on-year growth of 47.6%, reaching 1.219 billion yuan [1] - The company's cash flow situation is concerning, with cash and cash equivalents at 630 million yuan, down 9.48% year-on-year [3] - The ratio of accounts receivable to profit has reached an alarming 3189.85% [3] Business Model and Return on Investment - The company's return on invested capital (ROIC) was 2.5% last year, indicating weak capital returns [3] - The historical median ROIC since the company went public is 8.49%, with the worst year being 2023 at 2.29% [3] - The company's performance is primarily driven by research and marketing efforts, necessitating a deeper analysis of these drivers [3]
深圳市京泉华科技股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-28 09:18
Core Points - The company reported a total fundraising amount of approximately RMB 435.50 million from a non-public stock issuance, with a net amount of RMB 420.57 million after deducting issuance costs [7][9] - As of June 30, 2025, the company utilized RMB 262.20 million of the raised funds, including RMB 115.62 million for working capital and RMB 146.58 million for project investments [9][10] - The company has established strict management protocols for the raised funds, including special accounts and regulatory agreements to ensure proper usage [11][12] Fundraising Overview - The company issued 13,089,870 shares at a price of RMB 33.27 per share, with the funds arriving in the company's account on March 9, 2023 [7] - The company has not distributed cash dividends or bonus shares during the reporting period [2] Fund Usage - The total amount used from the raised funds includes RMB 115.62 million for working capital and RMB 146.58 million for project investments, with prior investments of RMB 53.01 million from self-owned funds [9][10] - The company has not used idle funds for temporary working capital or cash management during the reporting period [16][18] Changes in Fund Usage - The company approved changes in the use of part of the raised funds to invest in a new project with Guangdong Ruijin Electric Co., Ltd., establishing a new entity for the "Large Capacity Transformer Intelligent Production Line Construction Project" [12][20] - The company also approved a change in the project location to the Philippines for the "Renewable Energy Magnetic Integrated Device Intelligent Manufacturing Project" [20] Asset Impairment and Write-offs - The company recognized an asset impairment provision of RMB 1,949.93 million, including provisions for accounts receivable and inventory [33][37] - A total of RMB 204.69 million in uncollectible receivables was written off during the reporting period [34][35]
京泉华:8月26日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-28 01:34
Group 1 - The company Jingquan Hua held its fifth second board meeting on August 26, 2025, to review the proposal for the 2025 semi-annual financial report [1] - The meeting was conducted in a hybrid format, combining in-person attendance with communication technology [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into a human [1] - The discussion includes insights from key participants regarding the timeline for clinical application of this breakthrough [1]
京泉华(002885.SZ):上半年净利润4129.60万元 同比增长11.45%
Ge Long Hui A P P· 2025-08-27 12:50
格隆汇8月27日丨京泉华(002885.SZ)公布2025年半年度报告,上半年公司实现营业收入17.24亿元,同比 增长29.84%;归属于上市公司股东的净利润4129.60万元,同比增长11.45%;归属于上市公司股东的扣 除非经常性损益的净利润3566.12万元,同比增长29.37%;基本每股收益0.1519元。 ...
京泉华(002885) - 关于2025年半年度计提资产减值准备及核销资产的公告
2025-08-27 12:35
证券代码:002885 证券简称:京泉华 公告编号:2025-050 深圳市京泉华科技股份有限公司 关于 2025 年半年度计提资产减值准备及核销资产的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、计提资产减值准备及核销资产的情况概述 (一)计提资产减值准备的情况 深圳市京泉华科技股份有限公司(以下简称"公司")根据《企业会计准则》 《深圳证券交易所股票上市规则》及《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关规定,为更加真实、准确地反映公司截 至 2025 年 6 月 30 日的财务状况和经营成果,基于谨慎性原则,对公司合并报表 范围内各类资产进行了清查、分析和评估,对存在减值迹象的资产计提了减值准 备,对符合财务核销确认条件的资产经调查取证后,确认实际形成损失的资产予 以核销,具体情况如下: 单位:万元 | 项目 | 年初金额 | 本期计提 | 收回或 转回 | 核销或 转销 | 汇率变动 | 期末金额 | | --- | --- | --- | --- | --- | --- | --- | | 应收票据坏账准 ...
京泉华(002885) - 半年度非经营性资金占用及其他关联资金往来情况汇总表
2025-08-27 12:35
深圳市京泉华科技股份有限公司 | 其他关联资金往 | | | 往来方与上市 | 上市公司核算 | 2025年期 | 2025年1-6月 往来累计发生 | 2025年1-6月 | 2025年1-6月 | 2025年6月期 | | 往来性质(经营 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 来 | 资金往来方名称 | | 公司的关联关 | 的会计科目 | 初往来资 | 金额(不含利 | 往来资金的利 | 偿还累计发生 | 末往来资金余 | 往来形成原因 | 性往来、非经营 | | | | | 系 | | 金余额 | 息) | 息(如有) | 金额 | 额 | | 性往来) | | 控股股东、实际控 制人及其附属企 | | | | | | | | | | | | | 业 | | | | | | | | | | | | | 上市公司的子公 | 香港京泉华发展有限公司 | | 全资子公司 | 其他应收款 | 695.10 | | | 7.61 | 687.49 | 资金往来 | 非经营性往来 | | | JQ ...